Advertisement

European Journal of Epidemiology

, Volume 13, Issue 4, pp 417–420 | Cite as

Prevalence of Hepatitis A, B, and C markers in school children of a rural area of Crete, Greece

  • Christos Lionis
  • Effie Frangoulis
  • Maria Koulentakis
  • Evangelos Biziagos
  • Elias Kouroumalis
Article

Abstract

Objective: To determine the prevalence of hepatitis A, B, and C markers in children who were attending junior and senior high schools in a high risk area in rural Crete, Greece. Methods: Three-hundred and thirty-four children who attended the three junior schools and one senior high school in the Agios Vassilios province of Southern Crete were invited to participate in the study. Three hundred and four of them were tested for hepatitis A, B, and C markers. Hepatitis B (HBV) markers (HBsAg and anti-HBc) as well as hepatitis A (anti-HAV) and hepatitis (anti-HCV) antibodies were tested with commercial enzyme-linked immunosorbent assay kits. Results: Six of the 304 children (1.97%) were found to be positive for anti-HAV, 1 (0.33%) to HBsAg, 7 (2.30%) to anti-HBc and none were found positive for anti-HCV. No significant differences were seen between the prevalence of anti-HAV antibodies in males (2%) and females (1.95%), and of anti-HBc antibodies in males (3.33%) and females (1.30%). Conclusions: The very low prevalence of anti-HAV is obviously due to the improved conditions of hygiene and it raises the question of the possible emergence of this disease at an older age and therefore appropriate preventative strategies should be considered. The low endemicity of hepatitis B in Crete in contrast to other areas of Greece also calls for a vaccination policy probably during adolescence. The absence of hepatitis C markers in the children in contrast to the observed higher prevalence of HCV-infected people in the adult population in the same rural area raises questions regarding possible sources of transmission of hepatitis C during the preceding years.

Crete Greece Hepatitis A, B, C Prevalence Schoolchildren 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Papaevangelou G, Kyriakidou A, Visoulis C, Trichopoulos D. Sero-epidemiological study of HBV infections in Athens, Greece. J Hyg Camb 1976; 76: 229–234.Google Scholar
  2. 2.
    Frosner GG, Papaevangelou G, Butler R, et al. Antibody against hepatitis A in seven European Countries. Am J Epidem 1979; 110: 63–69.Google Scholar
  3. 3.
    National Statistical Service of Greece. Social Welfare and Health Statistics 1986, Athens 1989.Google Scholar
  4. 4.
    National Statistical Service of Greece. Social Welfare and Health Statistics 1988, Athens 1991.Google Scholar
  5. 5.
    National Statistical Service of Greece. Social Welfare and Health Statistics 1990, Athens 1993.Google Scholar
  6. 6.
    Lionis C, Koulentaki M, Biziagos E, Kouroumalis E. Current prevalence of hepatitis A, B and C in a well-defined area in rural Crete, Greece. J Viral Hep 1997; 4: 55–61.Google Scholar
  7. 7.
    Papaevangelou GJ. Epidemiology of Hepatitis A and B. Infection 1987; 15: 221–227.Google Scholar
  8. 8.
    Kane M, Alter M, Esteban R, Rizzeto M. Role of screening in prevention and treatment. Gut 1993; (suppl), S45–S47.Google Scholar
  9. 9.
    Papaevangelou GJ. Epidemiology of hepatitis A in Mediterranean countries. Vaccine 1992; 10(Suppl 1): S63–S66.Google Scholar
  10. 10.
    Arvantitdou M, Roumeliotou A, Grigoriadou A, Chrapalou K, Papaevangelou G. Hepatitis A prevalence in Greece. Acta Microbiol Hellenica 1989; 34: 365–371 (in Greek).Google Scholar
  11. 11.
    Hadziyiannis S, Dourakis S, Papaioannou C, Alexopoulou A, Hadziyiannis E, Gioustozi A. Changing epidemiology and spreading modalities of Hepatitis Delta Virus Infection in Greece. Prog Clin Biol Res 1993; 382: 259–266.Google Scholar
  12. 12.
    Gessoni G, Manoni F. Prevalence of anti-hepatitis C virus antibodies among teenagers in the Venetian area: A seroepidemiological study. Eur J Med 1993; 2: 79–82.Google Scholar
  13. 13.
    Tanaka E, Kiyosawa K, Sodeyama T, et al. Prevalence of antibody to hepatitis C virus in Japanese school-children: Comparison with adult blood donors. Am J Trop Med Hyg 1992; 46: 460–464.Google Scholar
  14. 14.
    Faleh Z, Al-Faleh E, Ayobanji A, et al. Prevalence of antibody to hepatitis C virus among Saudi Arabian children: A community based study. Hepatology 1991; 14: 215–222.Google Scholar
  15. 15.
    Schramm W, Roggendorf M, Rommel F, et al. Prevalence of antibodies to Hepatitis C (HCV) in haemophiliacs. Blut 1989; 59: 390–392.Google Scholar
  16. 16.
    Vranckx R, Van Damme P. Hepatitis C in institutionalized children. N Engl J Med 1990; 323: 64.Google Scholar
  17. 17.
    Trepo C, Zoulin F, Alonso C, Petit MA, Pichoud C, Vitvitski L. Diagnostic markers of viral hepatitis B and C. Gut 1993; suppl.: S20–S25.Google Scholar

Copyright information

© Kluwer Academic Publishers 1997

Authors and Affiliations

  • Christos Lionis
    • 1
  • Effie Frangoulis
    • 1
  • Maria Koulentakis
    • 2
  • Evangelos Biziagos
    • 2
  • Elias Kouroumalis
    • 2
  1. 1.Department of Social Medicine, Medical SchoolUniversity of CreteGreece
  2. 2.Liver Research Laboratory and Department of GastroenterologyUniversity Hospital and Medical SchoolHeraklion, CreteGreece

Personalised recommendations